ChemistrySelect,
Journal Year:
2021,
Volume and Issue:
6(40), P. 11137 - 11143
Published: Oct. 26, 2021
Abstract
Recently,
as
a
drug
target
in
cancer
treatment,
the
superfamily
of
glutathione
S‐transferase
(GSTs,
EC
2.5.1.18)
have
been
invited
considerable
interest
by
scientists.
In
particular,
they
are
overexpressed
many
human
cell
lines,
GSTs
can
catalyze
conjugation
cellular
nucleophile
(GSH)
with
wide
range
electrophilic
carcinogens
toxins
and
drugs,
meanwhile
producing
oxidative
stress.
For
this
purpose,
GST
was
purified
GSH‐agarose
affinity
chromatography,
some
calcium
channel
blockers
(CCBs),
such
amlodipine,
cinnarizine,
isradipine,
nifedipine,
nilvadipine,
were
assessed
for
their
inhibitory
actions
against
GST.
The
CCBs
demonstrated
micromolar
levels
activity
towards
(
K
I
s
spanning
within
98.84±0.53
μM–502.70±2.53
μM
range).
best
observed
isradipine.
Additionally,
molecular
docking
study
performed
competitive
inhibitor
nilvadipine
on
to
describe
possible
interaction
active
site
confirm
activity.
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2021,
Volume and Issue:
40(22), P. 12008 - 12021
Published: Aug. 23, 2021
Aldose
reductase
(AR)
and
sorbitol
dehydrogenase
(SDH)
are
important
enzymes
of
the
polyol
pathway.
In
current
study,
inhibitory
effects
vulpinic
acid
(VA)
carnosic
(CA)
usnic
(UA)
on
purified
AR
SDH
were
determined.
These
inhibition
could
be
essential
to
prevent
diabetic
complications.
from
sheep
kidney.
Then,
VA,
CA
UA
tested
in
various
concentrations
against
these
activity
vitro.
KI
values
found
as
1.46
±
0.04,
5.13
0.25
11.71
0.27
μΜ
for
UA,
respectively,
AR.
constants
15.32
0.34,
145.60
2.17
213.40
2.64
SDH.
findings
indicate
that
useful
treatment
complications.Communicated
by
Ramaswamy
H.
Sarma
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2021,
Volume and Issue:
40(19), P. 8752 - 8764
Published: May 5, 2021
The
underlying
cause
of
many
metabolic
diseases
is
abnormal
changes
in
enzyme
activity
metabolism.
Inhibition
enzymes
such
as
cholinesterases
(ChEs;
acetylcholinesterase,
AChE
and
butyrylcholinesterase,
BChE)
α-glucosidase
(α-GLY)
one
the
accepted
approaches
treatment
Alzheimer's
disease
(AD)
diabetes
mellitus
(DM).
Here
we
reported
an
investigation
a
new
series
novel
ureido-substituted
derivatives
with
sulfamethazine
backbone
(2a-f)
for
inhibition
AChE,
BChE,
α-GLY.
All
demonstrated
nanomolar
levels
α-GLY
inhibitors
KI
values
range
56.07-204.95
nM,
38.05-147.04
12.80-79.22
respectively.
Among
strong
N-(4,6-dimethylpyrimidin-2-yl)-4-(3-substitutedphenylureido)
benzenesulfonamide
detected
against
ChEs,
compound
2c,
4-fluorophenylureido
derivative,
most
potent
profile
towards
BChE.
A
comprehensive
ligand/receptor
interaction
prediction
was
performed
silico
three
providing
molecular
docking
using
Glide
XP,
MM-GBSA,
ADME-Tox
modules.
present
research
reinforces
rationale
behind
utilizing
innovative
anticholinergic
antidiabetic
agents
mechanism
action,
submitting
propositions
rational
design
synthesis
targeting
ChEs
α-GLY.Communicated
by
Ramaswamy
H.
Sarma.
ChemistrySelect,
Journal Year:
2021,
Volume and Issue:
6(29), P. 7278 - 7284
Published: Aug. 2, 2021
Abstract
Schiff
bases
display
superior
features
for
many
areas,
such
as
significant
intermediates
in
industrial
biological,
pharmacological,
catalytic
and
optical
properties,
organic
synthesis,
coordination
chemistry.
The
pre‐synthesized
two
base
ligands
(
HL
1
2
)
their
bidentate
metal
complexes
Co(L
,
Cu
L
Ni
were
tested
inhibition
activities
on
acetylcholinesterase
(AChE)
human
carbonic
anhydrase
h
CA
I
II)
isoforms.
transition
of
displayed
the
potent
effect
with
K
constants
ranging
from
16.39±0.15
to
88.63±0.27
nM
9.32±0.13
33.66±0.57
isoenzymes
AChE,
respectively.
compound
AChE
II
had
highest
inhibitory
effect.
Besides,
molecular
docking
analyses
most
active
performed
understand
binding
interactions
enzymes’
sites.
According
both
vitro
silico
analysis
results,
all
compounds
potential
inhibitors
I,
isoenzymes.
Archiv der Pharmazie,
Journal Year:
2021,
Volume and Issue:
354(12)
Published: Sept. 27, 2021
New
hybrid
thiazolyl-pyrazoline
derivatives
(4a-k)
were
obtained
through
a
facile
and
versatile
synthetic
procedure,
their
inhibitory
effects
on
the
human
carbonic
anhydrase
(hCA)
isoforms
I
II
as
well
acetylcholinesterase
(AChE)
determined.
All
new
thiazolyl-pyrazolines
showed
activity
at
nanomolar
levels
hCA
I,
II,
AChE
inhibitors,
with
KI
values
in
range
of
13.35-63.79,
7.01-115.80,
17.89-48.05
nM,
respectively.
1-[4-(4-Cyanophenyl)thiazol-2-yl]-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline
(4f)
1-(4-phenylthiazol-2-yl)-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline
(4a)
against
hCAs
1-[4-(4-chlorophenyl)thiazol-2-yl]-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline
(4d)
1-[4-(4-nitrophenyl)thiazol-2-yl]-3-(4-piperidinophenyl)-5-(4-fluorophenyl)-2-pyrazoline
(4b)
identified
highly
potent
superior
to
standard
drugs,
acetazolamide
tacrine,
Compounds
4a-k
also
evaluated
for
cytotoxic
L929
mouse
fibroblast
(normal)
cell
line.
Moreover,
comprehensive
ligand-receptor
interaction
prediction
was
performed
using
ADME-Tox,
Glide
XP,
MM-GBSA
modules
Schrödinger
Small-Molecule
Drug
Discovery
Suite
elucidate
potential
binding
modes
inhibitors
these
metabolic
enzymes.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(24), P. 15893 - 15893
Published: Dec. 14, 2022
Redox
equilibria
and
the
modulation
of
redox
signalling
play
crucial
roles
in
physiological
processes.
Overproduction
reactive
oxygen
species
(ROS)
disrupts
body's
antioxidant
defence,
compromising
homeostasis
increasing
oxidative
stress,
leading
to
development
several
diseases.
Manganese
superoxide
dismutase
(MnSOD)
is
a
principal
enzyme
that
protects
cells
from
damage
by
converting
anion
radicals
hydrogen
peroxide
mitochondria.
Systematic
studies
have
demonstrated
MnSOD
plays
an
indispensable
role
multiple
This
review
focuses
on
preclinical
evidence
describes
mechanisms
diseases
accompanied
with
imbalanced
status,
including
fibrotic
diseases,
inflammation,
diabetes,
vascular
neurodegenerative
cancer.
The
potential
therapeutic
effects
activators
mimetics
are
also
discussed.
Targeting
this
specific
radical
scavenger
may
be
clinically
beneficial
strategy,
understanding
provide
positive
insight
into
preventing
treating
related